Scientists developed a device that can help people with Tourette’s
University of Nottingham's Neupulse device provides electrical pulses to decrease tics frequency and intensity
The University of Nottingham and Neurotherapeutics Ltd. developed the device called Neupulse, which reduces the frequency and intensity of tics using electrical pulses. The clinical trial involved 121 participants in the UK, and the device reduced tic frequency by an average of 25%.
Scottish musician Lewis Capaldi, who recently revealed he has Tourette’s syndrome, tested the prototype wrist device and reported positive outcomes. The university and Neurotherapeutics Ltd. have received an additional £1 million in funding to market the device.
During the trial, participants used the device for 15 minutes daily for a month and provided weekly feedback.
Active stimulation significantly decreased the intensity and frequency of tics in those who used the device. A trial participant, Mylo, 13, reported that his tics were considerably reduced by the device. The Neupulse device could significantly improve the lives of people with Tourette’s syndrome by providing a non-invasive and effective way to manage their symptoms.
